We identified a novel ceftazidime/avibactam (CAZ/AVI) resistance mechanism in endemic sequence type 11 hypervirulent and carbapenem-resistant isolated from a patient who had not been exposed CAZ/AVI. Overexpression of caused by tandem gene amplification contributed to CAZ/AVI resistance instead of the carriage of . Enhanced genomic surveillance is essential to identify emerging variants.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11565672 | PMC |
| http://dx.doi.org/10.1080/22221751.2024.2426481 | DOI Listing |
Publication Analysis
Top Keywords
overexpression caused
8
caused tandem
8
amplification contributed
8
hypervirulent carbapenem-resistant
8
caz/avi resistance
8
tandem amplification
4
contributed ceftazidime/avibactam
4
ceftazidime/avibactam resistance
4
resistance hypervirulent
4
carbapenem-resistant identified
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!